Table 1.
Breast Cancer Subtype | Cell Line | SOCE Constituents | References |
Estrogen receptor positive | MCF7 | STIM1, STIM2, Orai3 and TRPC6 | [50,53,82,83,84] |
Triple Negative/Basal | MDA-MB-231 | STIM1, Orai1 and TRPC6 | [53,82,83,84] |
Breast Cancer Subtype | Cell Line | SOCE Remodeling | References |
Estrogen receptor positive | MCF7 | ↓STIM1, ↔STIM2, ↑Orai3 and ↑TRPC6 | [50,53,82,83,84] |
HCC 1500 | ↔STIM1 | [83] | |
ZR751 | ↔STIM1 | [83] | |
T47D | ↓STIM1 | [83] | |
BT474 | ↓STIM1 | [83] | |
HER2 | HCC1569 | ↑TRPC1 | [85] |
Triple Negative/Basal | MDA-MB-231 | ↔STIM1, ↑Orai1, ↑TRPC1 and ↑TRPC6 | [53,82,83,84,86] |
MDA-MB-468 | ↑TRPC1 | [86] | |
BT20 | ↑STIM1 | [83] | |
HCC 1937 | ↔STIM1 | [83] | |
Patients | ↑STIM1, ↓STIM2 and ↑TRPC6 | [49] |
↔ Similar levels in cancer and non-tumoral cells. ↑ Increased levels in cancer cells. ↓ Decreased levels in cancer cells.